| LADIX | VIVIX | LADIX / VIVIX | |
| Total Expense Ratio | 1.17 | 0.04 | 2,925% |
| Annual Report Gross Expense Ratio | 1.17 | 0.04 | 2,925% |
| Fund Existence | 18 years | 27 years | - |
| Gain YTD | 3.697 | 11.991 | 31% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 5000000 | 20% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 356M | 208B | 0% |
| Annual Yield % from dividends | 3.28 | 2.10 | 156% |
| Returns for 1 year | 3.27 | 6.69 | 49% |
| Returns for 3 years | 43.24 | 33.49 | 129% |
| Returns for 5 years | 79.78 | 66.36 | 120% |
| Returns for 10 years | 128.44 | 134.98 | 95% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| OGMIX | 55.40 | 1.69 | +3.15% |
| Invesco Gold & Special Minerals R6 | |||
| MCYAX | 13.96 | 0.05 | +0.36% |
| NYLI Candriam Emerging Markets Eq Cl A | |||
| RMFHX | 62.88 | 0.14 | +0.22% |
| American Funds American Mutual R5E | |||
| GSESX | 71.05 | 0.02 | +0.03% |
| Goldman Sachs US Equity Insights Svc | |||
| MUOSX | 34.86 | N/A | N/A |
| Morgan Stanley Instl US Core R6 | |||